Company Management

Desentum Oy

Pharmaceutical Manufacturing Espoo, Uusimaa, Fi 12 employees

Employees: 12
Contacts: 2
Emails: 2

desentum.com LinkedIn Crunchbase

Desentum Oy Overview

Headquarters: Espoo, Uusimaa, Fi
Website: desentum.com
Industry: Pharmaceutical Manufacturing
Employees: 12
Founded: 2011
Funding: 12.9M
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

immunotherapy and allergy vaccines

About Desentum Oy

Desentum is a clinical-stage, research-oriented biopharmaceutical company specialized in developing novel types of allergy immunotherapy products (aka allergy vaccines) that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. We have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivity reaction, we have made discoveries that allow for improved design of vaccines against common types of allergies. Our goal is to provide long-term relief from allergic symptoms with only a few months of treatment, as well as reduce the social and economic burden allergies cause to both individuals and society.

Desentum Oy Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage

Desentum Oy Org Chart

Sample employees and titles

Name	Title	Location	Contact
Dirk-Jan Opstelten	Principal Consultant and Owner	The Hague, South Holland, Netherlands	Email
Pekka Mattila	CEO at Desentum Oy	Espoo, Uusimaa, Finland	Email
Stina Wallmark	Investment Director Life Sciences		View